Protecting our clients and their products is our highest priority.
Companies that make products come to our team to avoid disputes or resolve them quickly in order to get back to business.
With a deep understanding of your business and industry, we partner with you proactively to review industry standards and government regulation compliance. We advise on improvements in product testing, warnings and recordkeeping to reduce ongoing litigation and avoidance of future lawsuits.
Litigation is expensive and unpredictable.
Our team controls costs without compromise. We begin with an early case evaluation to form an educated assessment of litigation risks. We staff our cases efficiently using scalable teams and employ state-of-the-art case management tools.
We know how to talk to juries and have the experience to jump in and handle a client’s case at a moment’s notice, regardless of the subject matter.
With extensive experience in class action, multijurisdictional and multidistrict litigation, we have successfully tried high-exposure cases to verdicts in some of the most challenging venues across the country. We are recognized by general counsel in the BTI Litigation Outlook 2016 as one of the top three “powerhouse” firms for product liability litigation.
Our full-service 24/7 Crisis Response team guides clients through accident investigations and high profile crises.
Product manufacturers of every kind including those in the following industries:
Law360 | July 24, 2020
Complex Commercial Disputes co-practice group leader and Boston partner Steve LaRose and Manchester associate Kierstan Schultz were mentioned in this article for representing Aetna in a suit regarding coverage for medical device manufacturer Conformis’ customized total knee implants.
Law360 | June 25, 2020
This article, covering a federal judge’s dismissal of claims against NP client Bayer Corp. related to the company’s Essure birth control device, mentions Buffalo Complex Commercial Disputes partner Vivian Quinn and counsel Tracey Scarpello for representing Bayer.
Defense Research Institute | September 04, 2019
Complex Commercial Disputes partner Vivian Quinn and associate Tracey Scarpello, both of the Buffalo office, co-wrote this article in the Defense Research Institute’s publication, analyzing the impact of the ascertainability requirement on pharmaceutical and medical device class actions.
Food, Beverage & Agribusiness Alert | 01.04.22
Class Action Alert | 04.13.20
Interstate Commerce Alert | 03.20.20
Cannabis Alert | 01.13.20
Privacy Law Alert | 09.16.19